Table 2.

Clinical and demographic characteristics of survivors and non-survivors.

	Survivors (n = 89)	SD or IQR25-75%	Non-survivors (n = 95)	SD or IQR25-75%	p value
Mean age (years)	55.54	21.1	61.81	19.6	0.02
Male sex (%)	55.05	-	61.05	-	0.42
Hemodynamic instabilitya (%)	27.3	-	42.1	-	0.02
Need of MVb (%)	42.7	-	91.6	-	< 0.01
Median RRc	20.00	18–23	23.00	20–24	< 0.01
Mean SBPd	130.00	39.9	124.2	37.9	0.16
Median platelets count (x 10³)	203.00	144–269	191.00	129–255	0.07
Median GCSe	14.00	9–15	10.00	3–14	< 0.01
Mean SpO2 (%)	94.7	6.8	94.1	8.8	0.28
Mean creatinine levels	1.84	2.1	2.10	2.8	0.16
Mean bilirubin levels	1.21	1.6	1.83	1.4	0.03
Mean hospitalization time (days)	28.82	43.58	25.29	62.78	0.33
Mean length of ICUf stay (days)	10.5	14.8	14.1	22.3	0.10
Median SOFA	5.0	2–7	8.0	5–9	< 0.01
Median qSOFA	1.0	1–2	2.0	1–2	< 0.01

^aMean arterial pressure < 70 or need for vasoactive drugs/

^bMechanical ventilation.

^cRespiratory rate/

^dSystolic blood pressure.

^eGlasgow Coma Scale/

^fIntensive care unit.